Charles River Laboratories International, Inc. (CRL) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$0.04	-$0.02	-150.0%	—	$1B	—
Q1 26	$1.95	$2.06	+5.6%	—	$995.8M	—
Q4 25	$2.35	$2.39	+1.7%	—	$994.2M	—
Q3 25	$2.34	$2.43	+3.8%	—	$1B	—
Q2 25	$2.55	$3.12	+22.4%	—	$1B	—
Q1 25	$2.07	$2.34	+13.0%	—	$984.2M	—
Q4 24	$2.53	$2.66	+5.1%	—	$1B	—
Q3 24	$2.42	$2.59	+7.0%	—	$1B	—
Q2 24	$2.39	$2.8	+17.2%	—	$1B	—
Q1 24	$2.06	$2.27	+10.2%	—	$1B	—
Q4 23	$2.4	$2.46	+2.5%	—	$1B	—
Q3 23	$2.37	$2.72	+14.8%	—	$1B	—
Q2 23	$2.64	$2.69	+1.9%	—	$1.1B	—
Q1 23	$2.59	$2.78	+7.3%	—	$1B	—
Q4 22	$2.75	$2.98	+8.4%	—	$1.1B	—
Q3 22	$2.5	$2.63	+5.2%	—	$989.2M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	-$2.91	—	—	$4B	—
FY24	—	$0.2	—	—	$4B	—
FY23	—	$9.27	—	—	$4.1B	—
FY22	—	$9.57	—	—	$4B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$1.7B	$1.9B	$2.3B	$2.6B	$2.9B	$3.5B	$4B	$4.1B	$4B	$4B
YoY change	+23.3%	+10.5%	+22%	+15.7%	+11.5%	+21.1%	+12.3%	+3.86%	-1.92%	-0.85%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	1.7B	1.9B	2.3B	2.6B	2.9B	3.5B	4B	4.1B	4B	4B
Cost of revenue	1B	1.2B	1.4B	1.7B	1.9B	2.2B	2.5B	2.6B	2.7B	2.7B
Gross profit	644M	700.9M	840.1M	958.3M	1.1B	1.3B	1.5B	1.5B	1.3B	1.3B
Gross margin	38.3%	37.7%	37.1%	36.6%	36.7%	37.7%	36.8%	36.4%	32.9%	33%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	364.7M	371.3M	443.9M	517.6M	528.9M	619.9M	665.1M	747.9M	751M	743.1M
Operating expenses	364.7M	371.3M	443.9M	517.6M	528.9M	619.9M	665.1M	747.9M	751M	743.1M
Operating income	237.6M	288.3M	331.4M	351.2M	432.7M	589.9M	651M	617.3M	442.3M	401.1M
Operating margin	14.1%	15.5%	14.6%	13.4%	14.8%	16.7%	16.4%	14.9%	10.9%	9.99%
Non-operating income, net	11.8M	37.8M	13.3M	12.3M	100M	-35.9M	30.5M	95.5M	-231.5M	-398.6M
Pretax income	222.9M	297M	281.7M	304.1M	447.1M	480.7M	623M	581.3M	93.1M	-99.5M
Income tax	66.8M	171.4M	54.5M	50M	81.8M	81.9M	130.4M	100.9M	67.8M	42.7M
Net income	156.4M	125.4M	228.7M	254.1M	365.3M	398.8M	492.6M	480.4M	25.3M	-142.2M
Net margin	9.3%	6.75%	10.1%	9.69%	12.5%	11.3%	12.4%	11.6%	0.62%	-3.54%
EBITDA	377.3M	457.9M	507.2M	563.1M	768.5M	820.2M	986.1M	1B	796.1M	786.8M
EPS	3.29	2.6	4.72	5.17	7.35	7.77	9.57	9.27	0.2	-2.91
Diluted EPS	3.23	2.54	4.62	5.07	7.2	7.6	9.48	9.22	0.2	-2.91

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	1B	1B	1B	1B	1B	1B	984.2M	1B	1B	994.2M	995.8M	1B
Cost of revenue	664.8M	649.4M	666.7M	672.4M	660.7M	718.3M	666.4M	675.1M	666.1M	684.5M	701.2M	640.7M
Gross profit	361.8M	364.1M	344.8M	353.7M	349M	284.2M	317.7M	357.1M	338.8M	309.7M	294.7M	363.4M
Gross margin	35.2%	35.9%	34.1%	34.5%	34.6%	28.4%	32.3%	34.6%	33.7%	31.1%	29.6%	36.2%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	176.1M	197.1M	186.3M	169.8M	199.2M	195.7M	177.8M	191.5M	177.6M	196.1M	159.4M	228.9M
Operating expenses	176.1M	197.1M	186.3M	169.8M	199.2M	195.7M	177.8M	191.5M	177.6M	196.1M	159.4M	228.9M
Operating income	151.5M	132.9M	126M	151.7M	117.4M	47.3M	74.7M	100.1M	133.8M	92.5M	119.9M	119.9M
Operating margin	14.8%	13.1%	12.5%	14.8%	11.6%	4.72%	7.59%	9.7%	13.3%	9.31%	12%	11.9%
Non-operating income, net	-6.3M	107.7M	5.8M	-2.2M	2.6M	-237.7M	-12.2M	154K	-22.6M	-363.9M	-124.1M	-37.4M
Pretax income	112.9M	208.7M	99M	119.7M	91.2M	-216.8M	36M	71.4M	87.2M	-294.1M	-29.9M	53.2M
Income tax	24.9M	19.8M	24.5M	25.4M	20.9M	-3M	10.1M	18.7M	31.6M	-17.8M	-15.1M	53.9M
Net income	88M	189M	74.5M	94.3M	70.3M	-213.7M	25.9M	52.7M	55.6M	-276.3M	-14.8M	-760K
Net margin	8.57%	18.6%	7.36%	9.19%	6.96%	-21.3%	2.63%	5.11%	5.53%	-27.8%	-1.49%	-0.08%
EBITDA	225.5M	322.8M	219.4M	238.5M	209.7M	-86.5M	184.2M	220.9M	197.8M	-192M	64M	150.8M
EPS	1.7	—	1.31	1.75	1.34	-4.22	0.5	1.06	1.11	-5.62	-0.3	-0.03
Diluted EPS	1.69	—	1.3	1.74	1.33	-4.22	0.5	1.06	1.1	-5.62	-0.3	-0.03

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	3.6B	5.2B	5.4B	7.4B	12.4B	18.9B	11.1B	12.1B	9.5B	9.9B	14.2B
Enterprise value	4.7B	6.1B	6.9B	9.2B	14.3B	21.7B	13.9B	14.9B	12B	12.2B	16.9B
Shares outstanding	47M	47.5M	47.9M	48.7M	49.5M	50.3M	50.8M	51.2M	51.4M	49.6M	49.6M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	22.9	41.4	23.7	29.3	33.9	47.5	22.5	25.2	375	—	681.3
P/S	2.13	2.8	2.39	2.84	4.23	5.35	2.78	2.93	2.34	2.46	3.54
P/B	4.2	4.88	4.05	4.47	5.78	7.31	3.66	3.31	2.7	3.08	4.94
EV/EBITDA	12.4	13.4	13.6	16.4	18.6	26.4	14.1	14.4	15.1	15.6	19.9
EV/Sales	2.79	3.31	3.04	3.52	4.89	6.12	3.5	3.61	2.97	3.05	4.22
Earnings yield	4.37%	2.41%	4.21%	3.41%	2.95%	2.1%	4.45%	3.97%	0.27%	—	0.15%
FCF yield	7.3%	4.53%	5.55%	4.57%	3.07%	2.81%	2.66%	3.02%	5.29%	5.24%	3.3%
PEG	—	—	—	—	—	—	—	—	—	—	-6.63

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	38.3%	37.7%	37.1%	36.6%	36.7%	37.7%	36.8%	36.4%	32.9%	33%	36.2%
Operating margin	14.1%	15.5%	14.6%	13.4%	14.8%	16.7%	16.4%	14.9%	10.9%	9.99%	15.1%
Net margin	9.3%	6.75%	10.1%	9.69%	12.5%	11.3%	12.4%	11.6%	0.62%	-3.54%	-5.96%
ROE	18.3%	11.8%	17.1%	15.2%	17%	15.4%	16.3%	13.1%	0.72%	-4.43%	-7.52%
ROA	5.77%	4.28%	5.93%	5.41%	6.65%	5.68%	6.48%	5.86%	0.34%	-1.99%	4.11%
ROIC	8.45%	6.05%	9.51%	8.5%	8.68%	9.23%	8.74%	7.91%	1.99%	7.2%	8.14%
Return on tangible assets	44.9%	21.6%	163.6%	109.1%	122.9%	-76.4%	-6.5K%	173.5%	6.51%	-15.3%	-27.1%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	1.53	1.78	1.61	1.44	1.43	1.23	1.32	1.52	1.41	1.29	1.35
Quick ratio	1.31	1.54	1.38	1.21	1.21	1.04	1.08	1.16	1.13	1.02	1.04
Debt / equity	1.45	1.08	1.25	1.22	1.01	1.14	1.02	0.84	0.78	0.8	1.05
Debt / assets	0.46	0.39	0.43	0.43	0.39	0.42	0.41	0.37	0.36	0.36	0.4
Net debt / EBITDA	2.95	2.08	2.9	3.17	2.51	3.3	2.9	2.7	3.18	3	12.9
Interest coverage	9.05	11	5.42	5.99	6.17	7.5	11.5	5.25	1.74	0.07	-0.73
Effective tax rate	30%	57.7%	19.3%	16.5%	18.3%	17%	20.9%	17.4%	72.8%	0%	0%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	35.8	39.1	47.3	53.8	59	70.4	78.3	80.6	78.8	81	81.9
EPS (basic)	3.29	2.6	4.72	5.17	7.35	7.77	9.57	9.27	0.2	-2.91	-2.91
EPS (diluted)	3.23	2.54	4.62	5.07	7.2	7.6	9.48	9.22	0.2	-2.91	-4.8
Book value per share	18.2	22.4	27.9	34.2	43.3	51.5	59.5	71.4	68.3	64.8	59.5
FCF per share	5.56	4.96	6.28	6.99	7.67	10.6	5.8	7.13	9.76	10.5	7.72
Cash per share	2.58	4.05	4.09	4.9	4.63	4.82	4.6	5.4	3.79	4.31	4.02
Capex per share	—	—	—	—	—	—	—	—	—	—	4.41

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	—	—	—	—	—	—	—	—	—	—	5.29%
Capex / operating cash flow	—	—	—	—	—	—	—	—	—	—	148.3%
Payout ratio	—	—	—	—	—	—	—	—	—	—	0%
Dividend yield	—	—	—	—	—	—	—	—	—	—	0.41%

Yield

0.41%

trailing twelve months

Frequency

Monthly

Last dividend

$0.10

ex-dividend Nov 28, 1996

Payout ratio

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Nov 28, 1996	$0.10
Oct 29, 1996	$0.10
Sep 26, 1996	$0.10
Aug 28, 1996	$0.10
Jul 29, 1996	$0.10
Jun 26, 1996	$0.10
May 29, 1996	$0.10
Apr 26, 1996	$0.10

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$1B	$1B	$1B	$1B	$1B	$1B	$984.2M	$1B	$1B	$994.2M	$995.8M	$1B
YoY change	+3.79%	-7.85%	-1.73%	-3.19%	-1.64%	-1.08%	-2.71%	+0.59%	-0.49%	-0.83%	+1.18%	-2.72%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	121.4M	192.3M	196.3M	239M	229.4M	242.3M	233.9M	276.8M	194.6M	213.8M
Receivables	284M	335.8M	370.1M	395.7M	489M	489.5M	559.4M	578.1M	527.7M	518.7M
Inventory	95.8M	115M	127.9M	160.7M	185.7M	199.1M	255.8M	380.3M	278.5M	299.1M
Total current assets	656.8M	826.6M	897.8M	1B	1.2B	1.3B	1.4B	1.6B	1.4B	1.4B
Property, plant & equipment	-28.3M	-30.3M	-5.3M	177.9M	242.9M	596.5M	893.7M	979.9M	946.8M	919.1M
Goodwill & intangibles	2.4B	2.3B	3.7B	4.5B	5.2B	7.5B	7.6B	7.9B	7.1B	6.2B
Total assets	2.7B	2.9B	3.9B	4.7B	5.5B	7B	7.6B	8.2B	7.5B	7.1B
Accounts payable	68.5M	77.8M	66.3M	111.5M	122.5M	198.1M	205.9M	168.9M	140.3M	148.8M
Short-term debt	27.3M	31M	31.4M	58.9M	74.9M	36.1M	—	—	—	—
Total current liabilities	429.6M	463.5M	558.2M	710.2M	839.8M	1B	1.1B	1.1B	994.1M	1.1B
Long-term debt	1.2B	1.1B	1.6B	2B	2.1B	2.9B	3.1B	3.1B	2.7B	2.6B
Total liabilities	1.9B	1.9B	2.5B	3B	3.3B	4.4B	4.6B	4.5B	4B	3.9B
Shareholders' equity	853.8M	1.1B	1.3B	1.7B	2.1B	2.6B	3B	3.7B	3.5B	3.2B
Total debt	1.2B	1.1B	1.7B	2B	2.2B	3B	3.1B	3.1B	2.7B	2.6B
Net debt	1.1B	981.3M	1.5B	1.8B	1.9B	2.7B	2.9B	2.8B	2.5B	2.4B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	157.2M	276.8M	327M	179.2M	210.2M	194.6M	229.4M	182.8M	207.1M	213.8M	191.8M	192M
Receivables	592M	578.1M	590.6M	568.3M	557.8M	527.7M	556.9M	565.2M	537.4M	518.7M	512.7M	524.8M
Inventory	293M	380.3M	361.3M	349.1M	336.2M	278.5M	290.2M	279.6M	302.6M	299.1M	359.7M	346.3M
Total current assets	1.4B	1.6B	1.7B	1.5B	1.5B	1.4B	1.5B	1.5B	1.5B	1.4B	1.5B	1.5B
Property, plant & equipment	1.9B	979.9M	970M	938.6M	928M	946.8M	944.6M	909.9M	883.8M	919.1M	753.2M	728.6M
Goodwill & intangibles	7.5B	7.9B	7.8B	7.8B	7.8B	7.1B	7.1B	7.1B	7B	6.2B	6.6B	6.7B
Total assets	7.6B	8.2B	8.2B	7.9B	8B	7.5B	7.6B	7.6B	7.5B	7.1B	7.7B	7.5B
Accounts payable	136.3M	168.9M	129.7M	133.1M	136M	140.3M	149.3M	145.8M	169.6M	148.8M	134M	141M
Short-term debt	—	—	—	—	—	—	—	—	—	—	—	—
Total current liabilities	993.8M	1.1B	954.8M	947.5M	1B	994.1M	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B
Long-term debt	2.9B	3.1B	3.1B	2.8B	2.8B	2.7B	3B	2.8B	2.6B	2.6B	3.1B	3B
Total liabilities	4.3B	4.5B	4.4B	4.2B	4.2B	4B	4.3B	4.2B	4.1B	3.9B	4.7B	4.6B
Shareholders' equity	3.4B	3.7B	3.7B	3.8B	3.8B	3.5B	3.2B	3.4B	3.5B	3.2B	3B	2.9B
Total debt	2.9B	3.1B	3.1B	2.8B	2.8B	2.7B	3B	2.8B	2.6B	2.6B	3.1B	3B
Net debt	2.7B	2.8B	2.8B	2.7B	2.5B	2.5B	2.8B	2.6B	2.4B	2.4B	2.9B	2.8B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	156.1M	125.6M	227.2M	254.1M	365.3M	398.8M	492.6M	480.4M	25.3M	-142.2M
Depreciation & amortization	126.7M	131.2M	161.8M	198.1M	234.9M	265.5M	303.9M	314.1M	361.7M	403.3M
Stock-based compensation	43.6M	44M	47.3M	57.3M	56.3M	71.5M	73.6M	72M	69.9M	71.1M
Change in working capital	-28.7M	2.3M	-16.8M	2.8M	-66.8M	-1.4M	-110.4M	-114.8M	-2.7M	-65.2M
Operating cash flow	305.3M	330.6M	425.5M	493.3M	603.3M	678.7M	741.8M	704.2M	420M	737.6M
Capital expenditure	—	—	—	—	—	—	—	—	—	—
Investing cash flow	-637.4M	9.8M	-814.9M	-541M	-435M	-1.2B	-283.2M	-244.6M	-12.1M	9.8M
Dividends paid	—	—	—	—	—	—	—	—	—	—
Share repurchases	-12.3M	-106.9M	-13.8M	-18.1M	-24M	-40.7M	-38.7M	-24.2M	-119.2M	-360.7M
Financing cash flow	357.6M	-247.3M	520.4M	197.4M	662K	626.9M	-67.5M	-111.1M	-574.8M	-537.4M
Net change in cash	25.5M	93.1M	130.9M	149.7M	169M	96.5M	391.1M	348.5M	-166.9M	210M
Free cash flow	261.6M	235.6M	301.1M	340.4M	380M	532M	294.9M	365.4M	501.6M	518.5M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	88M	189M	74.5M	94.3M	70.3M	-213.7M	25.9M	52.7M	55.6M	-276.3M	-14.8M	-760K
Depreciation & amortization	78.9M	80.5M	85.4M	86.1M	88.2M	102.1M	120.4M	119.5M	85.2M	78.3M	67.2M	67.3M
Stock-based compensation	22.8M	19.5M	16.7M	16.6M	19.3M	17.2M	13.1M	17M	23.3M	17.6M	22.4M	19.8M
Change in working capital	-33.8M	54.4M	-27.1M	876K	40.3M	-16.8M	-14M	-12.6M	-48M	9.3M	-22.3M	-19.1M
Operating cash flow	147.9M	309.1M	150.4M	195.3M	219.9M	-139.7M	130.1M	175.2M	117M	-171.8M	17.7M	179.7M
Capital expenditure	—	—	—	—	—	—	—	-35.3M	-35.6M	-89M	-55.9M	-31.1M
Investing cash flow	-13.6M	-160M	-6.6M	-22.4M	17.4M	-488K	13.8M	-37.3M	-33.7M	-92.8M	-407.8M	28.1M
Dividends paid	—	—	—	—	—	—	—	—	—	—	—	—
Share repurchases	-38K	-139K	-9.4M	-8.9M	-100.8M	-124K	-353.1M	-7.4M	-93K	-96K	-208.3M	-115.6M
Financing cash flow	-166.8M	117.6M	-3.2M	-286.7M	-208.3M	-76.6M	-105.3M	-226.9M	-152.6M	-52.6M	346.5M	-165.1M
Net change in cash	-32.5M	266.7M	140.6M	-113.8M	29M	-216.9M	38.6M	-89M	-69.3M	-317.2M	-43.6M	42.8M
Free cash flow	139.5M	142.6M	50.7M	154M	213.1M	83.7M	112.4M	169.3M	178.2M	58.6M	-14.8M	148.6M

Charles River Laboratories International, Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement